Yu Gan

1.1k total citations
42 papers, 730 citations indexed

About

Yu Gan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Yu Gan has authored 42 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Yu Gan's work include Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Cancer-related molecular mechanisms research (7 papers). Yu Gan is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Cancer-related molecular mechanisms research (7 papers). Yu Gan collaborates with scholars based in China, United States and Canada. Yu Gan's co-authors include Yao He, Yuxin Tang, Guoyu Dai, Weiping Xia, Xuesen Dong, Zhi Chen, Xiang Chen, Ahn R. Lee, Bo Zhang and Ru Feng and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yu Gan

39 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Gan China 16 372 322 269 77 66 42 730
Jianing Tang China 14 484 1.3× 231 0.7× 232 0.9× 186 2.4× 39 0.6× 23 840
Jinan Guo China 16 343 0.9× 187 0.6× 196 0.7× 150 1.9× 53 0.8× 38 608
Jianfeng Zheng China 14 355 1.0× 103 0.3× 232 0.9× 105 1.4× 41 0.6× 47 633
Lei Yan China 15 342 0.9× 137 0.4× 162 0.6× 94 1.2× 25 0.4× 43 584
Chao Cai China 21 749 2.0× 290 0.9× 431 1.6× 149 1.9× 49 0.7× 43 1.0k
Koji Miyagawa Japan 14 355 1.0× 118 0.4× 130 0.5× 107 1.4× 34 0.5× 20 670
William Tse United States 17 419 1.1× 124 0.4× 116 0.4× 159 2.1× 33 0.5× 50 905

Countries citing papers authored by Yu Gan

Since Specialization
Citations

This map shows the geographic impact of Yu Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Gan more than expected).

Fields of papers citing papers by Yu Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Gan. The network helps show where Yu Gan may publish in the future.

Co-authorship network of co-authors of Yu Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Gan. A scholar is included among the top collaborators of Yu Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Gan. Yu Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xiao, Ling, Ming Zhou, Yujia Li, et al.. (2024). [68Ga]Ga‑PSMA‑617 PET-based radiomics model to identify candidates for active surveillance amongst patients with GGG 1–2 prostate cancer at biopsy. Cancer Imaging. 24(1). 86–86. 2 indexed citations
3.
Liang, Qi, Li Zhou, Yu Gan, et al.. (2023). Survivin degradation by bergenin overcomes pemetrexed resistance. Cellular Oncology. 46(6). 1837–1853. 8 indexed citations
4.
Dong, Xin, Yu Gan, Jie Ding, et al.. (2023). TRAF4-mediated ubiquitination-dependent activation of JNK/Bcl-xL drives radioresistance. Cell Death and Disease. 14(2). 102–102. 10 indexed citations
5.
Gan, Yu, et al.. (2023). A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer. Frontiers in Oncology. 13. 1146515–1146515. 4 indexed citations
6.
Gan, Yu, et al.. (2023). Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells. Pharmaceuticals. 16(2). 241–241. 13 indexed citations
7.
Gao, Xiaomei, Yongxiang Tang, Minfeng Chen, et al.. (2023). A prospective comparative study of [68Ga]Ga-RM26 and [68Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 50(7). 2177–2187. 17 indexed citations
8.
Zhang, Tao, et al.. (2023). Association between autophagy and acute pancreatitis. Frontiers in Genetics. 14. 998035–998035. 12 indexed citations
9.
Deng, Liang, Chao Li, Chenghui Huang, et al.. (2022). Superselective Prostate Artery Embolization for Treatment of Severe Haematuria Secondary to Rapid Progression of Treatment-Induced Neuroendocrine Prostate Cancer: A Case Report. SHILAP Revista de lepidopterología. 2 indexed citations
10.
Luo, Cong, Zhi Liu, Yu Gan, et al.. (2022). SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer. Journal of Translational Medicine. 20(1). 313–313. 3 indexed citations
11.
Li, Chao, et al.. (2022). Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate cancer. Frontiers in Cell and Developmental Biology. 10. 955669–955669. 13 indexed citations
12.
13.
Zhang, Bo, Xiang Chen, Ru Feng, et al.. (2021). Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis. Cell Death and Disease. 12(9). 843–843. 158 indexed citations
14.
Xia, Weiping, Yao He, Yu Gan, et al.. (2021). Long Non-coding RNA: An Emerging Contributor and Potential Therapeutic Target in Renal Fibrosis. Frontiers in Genetics. 12. 682904–682904. 20 indexed citations
15.
Xia, Weiping, Xiang Chen, Ru Feng, et al.. (2021). Knockdown of lncRNA XIST inhibited apoptosis and inflammation in renal fibrosis via microRNA-19b-mediated downregulation of SOX6. Molecular Immunology. 139. 87–96. 23 indexed citations
16.
Long, Zhi, Liang Deng, Chao Li, et al.. (2021). Loss of EHF facilitates the development of treatment-induced neuroendocrine prostate cancer. Cell Death and Disease. 12(1). 46–46. 15 indexed citations
17.
Gan, Yu, Tingting Feng, Yinan Li, et al.. (2020). LIN28B promotes the development of neuroendocrine prostate cancer. Journal of Clinical Investigation. 130(10). 5338–5348. 72 indexed citations
18.
Wei, Jingchao, Yu Gan, Xianzhen Jiang, et al.. (2018). Long non‐coding RNA H19 promotes TDRG1 expression and cisplatin resistance by sequestering miRNA‐106b‐5p in seminoma. Cancer Medicine. 7(12). 6247–6257. 40 indexed citations
19.
Lee, Ahn R., Yu Gan, Yuxin Tang, & Xuesen Dong. (2018). A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network. EBioMedicine. 35. 167–177. 42 indexed citations
20.
Li, Xin, Qian Cai, Chunyun Li, et al.. (2017). The PI3K/Akt/mTOR pathway is involved in CVB3-induced autophagy of HeLa cells. International Journal of Molecular Medicine. 40(1). 182–192. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianing Tang Breakdown of academic impact, for papers by Jinan Guo Breakdown of academic impact, for papers by Jianfeng Zheng Breakdown of academic impact, for papers by Lei Yan Breakdown of academic impact, for papers by Chao Cai Breakdown of academic impact, for papers by Koji Miyagawa Breakdown of academic impact, for papers by William Tse
Rankless by CCL
2026